Planned OU trials test opaganib after CAR T-cell therapy for high-risk myeloma
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine